Review
Published on 21 Nov 2024
The effectiveness of acupuncture in cancer pain treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1450105
Type at least 3 characters
1,765 articles
Articles
Review
Accepted on 20 Nov 2024
Research progress and treatment status of Malignant Ascites
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1390426
Systematic Review
Published on 20 Nov 2024
Clinicopathological significance and prognostic values of claudin18.2 expression in solid tumors: a systematic review and meta-analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1453906
Review
Accepted on 19 Nov 2024
Advances in DLL3-Targeted Therapies for Small Cell Lung Cancer: Challenges, Opportunities, and Future Directions
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1504139
Review
Accepted on 19 Nov 2024
Molecular glue degrader for tumor treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1512666
Case Report
Published on 19 Nov 2024
Invasive aspergillosis complicated in a patient with non-small cell lung cancer harboring RET fusion during treatment with RET-TKIs: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1431908
- 215 views
Original Research
Accepted on 18 Nov 2024
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1433256
Case Report
Published on 18 Nov 2024
Bevacizumab for the treatment of metastatic colorectal cancer complicated by abdominal aortic aneurysm and mural thrombus: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1416349
- 227 views
Original Research
Published on 15 Nov 2024
The role and mechanism of “eight famous herbals in Zhejiang” in cancer via network pharmacology and experimental validation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1475000
- 217 views
Review
Accepted on 14 Nov 2024
Targeting the SMURF2-HIF1α Axis: A New Frontier in Cancer Therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1484515
- 103 views
Original Research
Published on 12 Nov 2024
Bone marrow mesenchymal stem cell-derived exosomes improve cancer drug delivery in human cell lines and a mouse osteosarcoma model
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1482087
- 144 views
Original Research
Accepted on 11 Nov 2024
The Role of ATP6V0D2 in Breast Cancer: Associations with prognosis, immune characteristics, and TNBC progression
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1511810
Systematic Review
Accepted on 11 Nov 2024
Circular RNA CDR1as/ciRS-7--A Novel Biomarker in Solid Tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1468363
Review
Accepted on 11 Nov 2024
The role of N6-methyladenosine modification in tumor angiogenesis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1467850
Systematic Review
Published on 11 Nov 2024
The current state and trends of immunotherapy research in lung cancer: a review and bibliometric analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1428307
- 261 views
Review
Accepted on 08 Nov 2024
Potential Urinary Volatile Organic Compounds as Screening Markers in Cancer -A Review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1448760